THB 152.5
(-1.29%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | 9.54 Billion | 503.92 Million | 241.74 Billion | 85.73 Billion | 102.21 Billion | 151.39 Billion |
Net Income | 55.84 Billion | 46.58 Billion | 51.97 Billion | 41.34 Billion | 53.75 Billion | 54.6 Billion |
Depreciation & Amortization | 8.76 Billion | 8.58 Billion | 7.32 Billion | 8.73 Billion | 7.55 Billion | 7.39 Billion |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | -110.26 Billion | -106.38 Billion | 155.06 Billion | 6.96 Billion | 25.42 Billion | 64.49 Billion |
Other non-cash items | 55.19 Billion | 51.72 Billion | 27.38 Billion | 28.68 Billion | 15.48 Billion | 24.9 Billion |
Investing Cash Flow | -8 Billion | 25.77 Billion | -251.22 Billion | -70.58 Billion | -111.46 Billion | -142.9 Billion |
Investments in PPE | -8.89 Billion | -9.97 Billion | -5.42 Billion | -10.23 Billion | -6.21 Billion | -4.74 Billion |
Acquisitions | -3.57 Billion | -6.67 Billion | 4.5 Billion | 3.81 Billion | 2.74 Billion | 2.53 Billion |
Investment purchases | -209.52 Billion | -262.16 Billion | -558.59 Billion | -446.93 Billion | -504.8 Billion | -403.56 Billion |
Sales/Maturities of investments | 213.98 Billion | 304.53 Billion | 312.76 Billion | 386.51 Billion | 399.42 Billion | 265.37 Billion |
Other Investing Activities | 15.49 Million | 50.81 Million | -4.46 Billion | -3.75 Billion | -2.6 Billion | -2.5 Billion |
Financing Cash Flow | -9.9 Billion | -29.12 Billion | 7.48 Billion | -14.56 Billion | 3.9 Billion | -9.57 Billion |
Debt repayment | -22.95 Billion | -22.92 Billion | -16.01 Billion | -15.96 Billion | -10.92 Billion | -16.29 Billion |
Dividends payments | -9.47 Billion | -7.7 Billion | -7.1 Billion | -10.66 Billion | -9.57 Billion | -9.57 Billion |
Common Stock Repurchased | - | - | - | -3.2 Billion | - | - |
Common Stock Issuance | - | - | - | 190.12 Million | - | - |
Other Financing Activities | 22.53 Billion | 1.49 Billion | 30.6 Billion | 15.07 Billion | 24.39 Billion | 16.28 Billion |
Accounts receivables | - | - | - | - | - | - |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | -110.26 Billion | -106.38 Billion | 155.06 Billion | 6.96 Billion | 25.42 Billion | 64.49 Billion |
Cash at beginning of period | 57.11 Billion | 59.97 Billion | 61.96 Billion | 61.38 Billion | 66.73 Billion | 67.82 Billion |
Cash at end of period | 48.68 Billion | 57.11 Billion | 59.97 Billion | 61.96 Billion | 61.38 Billion | 66.73 Billion |
Capital Expenditure | -8.89 Billion | -9.97 Billion | -5.42 Billion | -10.23 Billion | -6.21 Billion | -4.74 Billion |
Effect of forex changes on cash | -57.33 Million | -10.16 Million | 5.82 Million | -3.02 Million | -6.12 Million | -1.97 Million |
Net cash flow / Change in cash | -8.42 Billion | -2.85 Billion | -1.99 Billion | 577.14 Million | -5.35 Billion | -1.08 Billion |
Free Cash Flow | 643.25 Million | -9.46 Billion | 236.31 Billion | 75.5 Billion | 95.99 Billion | 146.65 Billion |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 16.86 Billion | 17.75 Billion | 12.81 Billion | 55.84 Billion | 14.5 Billion | 14.43 Billion |
Depreciation & Amortization | 2.21 Billion | 2.24 Billion | 2.26 Billion | 8.76 Billion | 2.19 Billion | 2.19 Billion |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | -32.05 Billion | 4.7 Billion | -22.89 Billion | -110.26 Billion | -20.9 Billion | -29.82 Billion |
Other non-cash items | -37.43 Billion | -38.51 Billion | 14.04 Billion | 55.19 Billion | 10.66 Billion | 17.33 Billion |
Investing Cash Flow | 11.23 Billion | -44.33 Billion | 5.47 Billion | -8 Billion | 8.97 Billion | -313.36 Million |
Investments in PPE | -1.98 Billion | -2.25 Billion | -2.87 Billion | -8.89 Billion | -2.24 Billion | -1.97 Billion |
Acquisitions | -182.65 Million | -75 Million | 2.11 Billion | -3.57 Billion | 938.08 Million | -56.25 Million |
Investment purchases | -89.06 Billion | -95.1 Billion | -55.4 Billion | -209.52 Billion | -38.62 Billion | -43.9 Billion |
Sales/Maturities of investments | 102.44 Billion | 53.06 Billion | 67.33 Billion | 213.98 Billion | 49.77 Billion | 45.62 Billion |
Other Investing Activities | 23.69 Billion | -43.49 Billion | -5.68 Billion | 15.49 Million | -879.36 Million | 136 Thousand |
Financing Cash Flow | -15.01 Billion | -739.19 Million | -4.62 Billion | -9.9 Billion | -19.65 Billion | -5.46 Billion |
Debt repayment | -385.81 Million | -257.7 Million | -4.49 Billion | -22.95 Billion | -17.67 Billion | -409.39 Million |
Dividends payments | -14.21 Billion | -481.49 Million | - | -9.47 Billion | -1.18 Billion | -8.29 Billion |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | -409.65 Million | -481.49 Million | -135.17 Million | 22.53 Billion | -796.92 Million | 3.23 Billion |
Accounts receivables | - | - | - | - | - | - |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | -28.61 Billion | -7 Billion | -22.89 Billion | -110.26 Billion | -20.9 Billion | -29.82 Billion |
Cash at beginning of period | 35.7 Billion | 48.68 Billion | 41.67 Billion | 57.11 Billion | 45.87 Billion | 47.52 Billion |
Cash at end of period | 30.26 Billion | 35.7 Billion | 48.68 Billion | 48.68 Billion | 41.67 Billion | 45.87 Billion |
Capital Expenditure | -1.98 Billion | -2.25 Billion | -2.87 Billion | -8.89 Billion | -2.24 Billion | -1.97 Billion |
Effect of forex changes on cash | 18.84 Million | 48.25 Million | -73.73 Million | -57.33 Million | 26.92 Million | -16.99 Million |
Net cash flow / Change in cash | -5.44 Billion | -12.98 Billion | 7.01 Billion | -8.42 Billion | -4.19 Billion | -1.65 Billion |
Free Cash Flow | -3.67 Billion | 29.78 Billion | 3.35 Billion | 643.25 Million | 4.21 Billion | 2.16 Billion |
601186
ZRE
300217
NEOGEN
6310
GNZUF